FibriCheck’s pulse beating stronger than ever in 2021
We started 2021 off strong with a new investment round. The newly invested 9 million euros allowed us to further…
FibriCheck statement on Log4j vulnerability
FibriCheck is aware of the Log4j zero-day vulnerability in the Java logging framework. This vulnerability is being tracked as CVE-2021-442281/2…
World Heart Rhythm Week: listening to your heart saves lives
Atrial fibrillation (AF) is the most common heart rhythm disorder. People as young as 40 have a 1 in 4…
BeHRA and FibriCheck join forces for Heart Rhythm Week
On the occasion of Heart Rhythm Week, the Belgian Heart Rhythm Association (BeHRA) in association with FibriCheck is organising a…
FibriCheck brings TGA-certified heart health app to Australia
FibriCheck, the app capable of detecting heart rhythm disorders like atrial fibrillation, is now available in Australia for use with…
Daiichi Sankyo and FibriCheck announce digital partnership set to transform at-home AF detection and diagnosis
Atrial Fibrillation (AF) is one of the leading causes of stroke and often goes undiagnosed due to lack of symptoms.1…
9 million euros in funding for eHealth pioneer Qompium
Hasselt, February 3, 2021 - Qompium, the pioneering Belgian digital health company, has received an additional 9 million euros in funding…
Safeguarding continuity of care in the UK during the pandemic
As TeleCheck AF continues to gain traction across the continent, notable strides are being made in the UK, where recently published…
2020: a year of challenges and triumphs for FibriCheck
It’s been an exciting year for FibriCheck! And looking back at everything we achieved together with our partners in 2020,…
CE approval for revolutionary (semi-)continuous monitoring technology
People suffering from potential heart rhythm disorders will soon be able to sleep a little easier. Because FibriCheck’s (semi-)continuous heart rhythm…
Dutch clinic prescribes remote monitoring to 777 heart patients during the COVID-19 pandemic
FibriCheck enables large scale teleconsultations at Maastricht University Medical Centre+
First step towards the Asia-Pacific region
FibriCheck gains approval from Australia’s Therapeutic Goods Administration (TGA) FibriCheck, the mobile app capable of detecting heart rhythm disorders, was…